Financials

  • Market Capitalization 4.49 M
  • Employee 1
  • Founded 2020
  • CEO N/A
  • Website liminatuspharma.com
  • Headquarter Delaware, United States
  • FIGI BBG01HVYG111
  • Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物

Related tickers

#名前価格24時間%7日%1か月%1年%時価総額過去7日
4981
CLGN
CollPlant Biotechnologies Ltd. - Ordinary Shares
0.37 USD+5.71%+2.78%+8.82%-79.44%4.74 M USD
4986
ALZN
Alzamend Neuro, Inc. - Common Stock
1.21 USD+4.31%+11.01%-4.72%-62.54%4.60 M USD
4993
FBLG
FibroBiologics, Inc. - Common Stock
0.85 USD-1.16%+3.66%-2.30%+23.19%4.43 M USD
5002
ENSC
Ensysce Biosciences, Inc. - Common Stock
0.29 USD+3.57%+3.57%+7.41%-24.18%4.26 M USD